0001792044 2020-11-16 2020-11-16 0001792044 dei:FormerAddressMember 2020-11-16 2020-11-16 true 0001792044 8-K/A 2020-11-16 VIATRIS INC. DE 001-39695 83-4364296 1000 Mylan Boulevard Canonsburg PA 15317 724 514-1800 Upjohn Inc. 235 East 42nd Street New York NY 10017 false false false false Common Stock, par value $0.01 per share VTRS NASDAQ false On November 19, 2020, Viatris Inc., formerly known as Upjohn Inc. (“Viatris”), filed a Current Report on Form 8-K (the “Original Report”) to report the consummation of the previously announced transaction between Viatris, Mylan N.V. (“Mylan”) and Pfizer Inc. (“Pfizer”), involving the combination of Mylan and Pfizer’s off-patent branded and generic established medicines business (the “Upjohn Business”) through a Reverse Morris Trust transaction, and related matters under Items 1.01, 2.01, 2.05, 5.01, 5.02, 5.03, 5.05 and 9.01 of Form 8-K. Due to the large number of events related to the transaction that are being reported under the specified items of Form 8-K, this Amendment No. 1 to the Original Report is being filed on Form 8-K/A solely to include additional matters under Items 1.01, 1.02, 2.03, 8.01 and 9.01 of Form 8-K.